Lack of significant association between dyslipidemia and COVID-19 mortality

J Infect. 2021 Jun;82(6):276-316. doi: 10.1016/j.jinf.2021.03.001. Epub 2021 Mar 5.

Authors

Haiyan Yang¹, Hongjie Hou², Xuan Liang², Jie Xu², Yadong Wang³

Affiliations

¹ Department of Epidemiology, School of Public Health, Zhengzhou University, No. 100 of Science Avenue, Zhengzhou 450001, China. Electronic address: yhy@zzu.edu.cn.
² Department of Epidemiology, School of Public Health, Zhengzhou University, No. 100 of Science Avenue, Zhengzhou 450001, China.
³ Department of Toxicology, Henan Center for Disease Control and Prevention, Zhengzhou 450016, China.

No abstract available

Keywords: COVID-19; Dyslipidemia; Meta-analysis; Mortality.

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

COVID-19*
Dyslipidemias* / complications
Genotype
Humans
Peptidyl-Dipeptidase A
SARS-CoV-2

Substances

Peptidyl-Dipeptidase A